ClinicalTrials.gg
CompletedNCT07497659Updated Mar 27, 2026

Ischemic Preconditioning in Resistance Exercise in Older Women

An interventional study of Ischemic Preconditioning and Sham Preconditioning in Blood Pressure, Hemodynamic Response and Rating of Perceived Exertion, sponsored by Universidade Federal do Triangulo Mineiro. Completed at 1 site in Brazil. Open to female participants aged 60 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Universidade Federal do Triangulo Mineiro · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled May 2025, registered Mar 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
60 Years to 70 Years
Sex
Female
01

Study summary

This study investigates whether ischemic preconditioning (IPC) can reduce cardiac demand after resistance exercise in older women.

Aging is associated with increased cardiovascular stress, especially due to elevated blood pressure and cardiac demand during and after exercise. Strategies that can reduce this overload may improve exercise safety in older women.

This is a randomized, single-blind, crossover clinical trial involving 30 women aged 60 years or older. Participants perform two conditions: ischemic preconditioning (IPC) and a sham condition (SHAM), followed by a standardized resistance exercise session.

The primary outcome is cardiac workload, assessed by the rate-pressure product (systolic blood pressure × heart rate) during post-exercise recovery. Secondary outcomes include blood pressure, heart rate, and heart rate recovery.

The results of this study may contribute to safer exercise strategies for older women.

Read the detailed description

Aging is associated with significant cardiovascular alterations, including increased arterial stiffness, impaired endothelial function, and elevated cardiac workload during and after physical exercise. In older women, these changes are exacerbated by postmenopausal hormonal decline, increasing vulnerability to cardiovascular stress.

Resistance exercise is recommended to improve strength, functional capacity, and overall health in older adults. However, it may induce acute increases in blood pressure and myocardial workload, particularly in individuals with reduced vascular compliance and impaired autonomic regulation. These responses may persist into the recovery period, increasing cardiovascular risk.

Ischemic preconditioning (IPC) is a non-pharmacological intervention that involves repeated cycles of vascular occlusion and reperfusion. This procedure can promote vascular adaptations, including increased nitric oxide bioavailability, improved endothelial function, and reduced peripheral vascular resistance. These mechanisms may contribute to attenuating hemodynamic stress during and after exercise.

Although IPC has shown promising results in young adults and clinical populations, there is limited evidence regarding its effects on hemodynamic responses following resistance exercise in older women.

This study is designed as a randomized, single-blind, crossover clinical trial including 30 physically independent women aged 60 years or older. Participants will complete two experimental conditions in randomized order: ischemic preconditioning (IPC) and a sham condition (SHAM).

The IPC protocol consists of three cycles of 3 minutes of arterial occlusion at a pressure 50 mmHg above systolic blood pressure, interspersed with 3 minutes of reperfusion. The sham condition consists of the same procedure with a fixed low pressure (20 mmHg), insufficient to induce arterial occlusion.

After each intervention, participants will perform a standardized resistance exercise session composed of four exercises: horizontal row, bench press, leg extension, and 45-degree leg press. The intensity will be set at 80% of 10-repetition maximum, with three sets of 10 repetitions per exercise and standardized rest intervals.

Hemodynamic variables will be assessed at rest, after the intervention, during exercise, and during recovery. The primary outcome is cardiac workload, assessed by the rate-pressure product, measured 20 minutes after exercise.

Secondary outcomes include systolic, diastolic, and mean arterial blood pressure, heart rate, and heart rate recovery at 60 seconds. Perceptual variables will be used to ensure similar baseline conditions between sessions.

Statistical analysis will be performed using linear mixed models, including condition, period, and sequence as fixed effects, with baseline values as covariates and random intercepts for participants.

02

Conditions studied

  • Blood Pressure
  • Hemodynamic Response
  • Rating of Perceived Exertion
  • Heart Rate

Keywords

  • blood pressure
  • ischemic preconditioning
  • menopause
  • resistance exercise
03

In context

Lead sponsor

Universidade Federal do Triangulo Mineiro is the lead sponsor of 12 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants aged 60 years or older
  • Physically independent
  • Engaged in regular physical activity (at least two sessions per week for the last three months)
  • Cleared for exercise participation by a cardiologist following clinical evaluation
  • Able to safely perform resistance exercise
  • Provided written

Exclusion criteria

Exclusion Criteria:

  • - History of cardiovascular events such as myocardial infarction or stroke
  • Uncontrolled hypertension (≥160/105 mmHg)
  • Diabetes mellitus
  • Current smoking or alcohol abuse
  • Musculoskeletal limitations that impair exercise performance
  • Cognitive or communication impairments that interfere with understanding instructions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Ischemic Preconditioning (IPC)

    Participants undergo ischemic preconditioning applied with one blood pressure cuff positioned on the proximal region of the thighs in an alternating unilateral manner. The protocol consists of three cycles of 3 minutes of arterial occlusion at a pressure 50 mmHg above systolic blood pressure, interspersed with 3 minutes of reperfusion. While one thigh receives occlusion, the contralateral thigh remains in reperfusion, alternating throughout the protocol. The procedure is performed before a standardized resistance exercise session.

    Device: Ischemic Preconditioning

  • Sham comparator
    SHAM

    Participants undergo a sham procedure using one blood pressure cuff applied to the proximal thighs in an alternating unilateral manner. The protocol follows the same timing and alternation pattern as the ischemic preconditioning condition, but with a fixed pressure of 20 mmHg, which is insufficient to produce arterial occlusion. The procedure is performed before a standardized resistance exercise session.

    Device: Sham Preconditioning

Interventions

  • DeviceIschemic Preconditioning

    Ischemic preconditioning consists of three cycles of 3 minutes of arterial occlusion at a pressure 50 mmHg above systolic blood pressure, interspersed with 3 minutes of reperfusion. The procedure is applied using a blood pressure cuff positioned on the proximal thighs in an alternating unilateral manner, where one limb undergoes occlusion while the contralateral limb remains in reperfusion. The intervention is performed prior to a standardized resistance exercise session.

  • DeviceSham Preconditioning

    The sham condition consists of the same procedure and timing as the ischemic preconditioning protocol, using a blood pressure cuff applied to the proximal thighs in an alternating unilateral manner. However, a fixed pressure of 20 mmHg is applied, which is insufficient to induce arterial occlusion. The procedure is performed prior to a standardized resistance exercise session.

06

What researchers measure

Primary outcomes

  1. Cardiac workload (rate-pressure product)

    Cardiac workload will be assessed by the rate-pressure product (RPP), calculated as systolic blood pressure multiplied by heart rate. This measure represents an indirect index of myocardial oxygen demand and cardiac stress.

    Time frame: 20 minutes post-exercise

Secondary outcomes

  1. Systolic blood pressure

    Systolic blood pressure will be measured during post-exercise recovery. This variable is also used to calculate the rate-pressure product, the primary outcome of the study.

    Time frame: 20 minutes post-exercise

  2. Mean arterial pressure

    Mean arterial pressure will be calculated as diastolic blood pressure plus one-third of pulse pressure.

    Time frame: 20 minutes post-exercise

  3. Diastolic blood pressure

    Diastolic blood pressure will be measured during post-exercise recovery under both ischemic preconditioning (IPC) and sham conditions. This variable reflects peripheral vascular resistance and contributes to the characterization of hemodynamic responses following resistance exercise. Diastolic blood pressure will also be considered alongside systolic blood pressure for the calculation of mean arterial pressure.

    Time frame: 20 minutes post-exercise

  4. Heart rate

    Heart rate will be measured during post-exercise recovery under both ischemic preconditioning (IPC) and sham conditions. This variable reflects cardiac chronotropic response and contributes to the assessment of cardiovascular load following resistance exercise. Heart rate will also be used in combination with systolic blood pressure to calculate the rate-pressure product, the primary outcome of the study.

    Time frame: 20 minutes post-exercise

  5. Heart Rate Recovery (HRR60)

    Heart rate recovery will be defined as the difference between peak heart rate at the end of exercise and heart rate at 60 seconds of recovery under both ischemic preconditioning (IPC) and sham conditions. This variable reflects autonomic regulation, particularly parasympathetic reactivation following exercise, and is considered an important indicator of cardiovascular function and recovery capacity.

    Time frame: 60 seconds post-exercise

07

Study locations

1 site
  • Federal University of Triângulo Mineiro (UFTM)
    Uberaba, Minas Gerais +55, Brazil
08

References and documents

Publications

  • Meng R, Ding Y, Asmaro K, Brogan D, Meng L, Sui M, Shi J, Duan Y, Sun Z, Yu Y, Jia J, Ji X. Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment. Neurotherapeutics. 2015 Jul;12(3):667-77. doi: 10.1007/s13311-015-0358-6. PubMed 25956401 ↗
  • Mota GR, Rightmire ZB, Martin JS, McDonald JR, Kavazis AN, Pascoe DD, Gladden LB. Ischemic preconditioning has no effect on maximal arm cycling exercise in women. Eur J Appl Physiol. 2020 Feb;120(2):369-380. doi: 10.1007/s00421-019-04281-9. Epub 2019 Dec 7. PubMed 31813045 ↗
  • American College of Sports Medicine; Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem GJ, Skinner JS. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009 Jul;41(7):1510-30. doi: 10.1249/MSS.0b013e3181a0c95c. PubMed 19516148 ↗
  • Queiroz AC, Kanegusuku H, Chehuen MR, Costa LA, Wallerstein LF, Dias da Silva VJ, Mello MT, Ugrinowitsch C, Forjaz CL. Cardiac work remains high after strength exercise in elderly. Int J Sports Med. 2013 May;34(5):391-7. doi: 10.1055/s-0032-1323779. Epub 2012 Nov 22. PubMed 23175179 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared due to privacy and confidentiality considerations. The dataset is small and may allow participant identification.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Sep 2025, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Mar 27, 2026
StartActual
May 28, 2025
Primary completionActual
Sep 18, 2025
CompletionActual
Sep 18, 2025
Last update
Mar 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07497659
Lead sponsor
Universidade Federal do Triangulo Mineiro
Responsible party
Gustavo Ribeiro da Mota (Full Professor (PhD), Universidade Federal do Triangulo Mineiro) — Principal investigator
First posted
Mar 27, 2026
Start date
May 28, 2025
Primary completion
Sep 18, 2025
Completion
Sep 18, 2025
Last update
Mar 27, 2026

Study contacts

Gustavo Mota, PhD
principal investigator · Federal University of Triângulo Mineiro (UFTM)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion